pillbase.ru

Decitabine

Active substance: decitabine

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DECITABINE 50 mg/10mL

United StatesActive

Marketing holder: BluePoint Laboratories

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Dacogen
    decitabine
    EMEA/H/C/002221
  • Inaqovi
    cedazuridine, decitabine
    EMEA/H/C/005823
    Otsuka Pharmaceutical Netherlands B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-a1e5-7778-aec5-2ce49d64b788,01a1208d-4297-71b7-8c53-c31dbe9e075d,01a1208e-17b5-7cf2-b7a2-0a97b4e44cd8,01a1208e-b430-7272-88a5-7b0ee5dc7a20,01a1208e-b795-7f21-ab3e-8abfc8a8243c;count=22 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
68001-713
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 68001-713 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 68001-713 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 68001-713 · Verified 2026-10-09 · open in source